Anti-TIMM17B monoclonal antibody

Pre-made anti-TIMM17B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TIMM17B/TIMM17B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1914-Ab-1/ GM-Tg-hg-IP1914-Ab-2Anti-Human TIMM17B monoclonal antibodyHuman
GM-Tg-rg-IP1914-Ab-1/ GM-Tg-rg-IP1914-Ab-2Anti-Rat TIMM17B monoclonal antibodyRat
GM-Tg-mg-IP1914-Ab-1/ GM-Tg-mg-IP1914-Ab-2Anti-Mouse TIMM17B monoclonal antibodyMouse
GM-Tg-cynog-IP1914-Ab-1/ GM-Tg-cynog-IP1914-Ab-2Anti-Cynomolgus/ Rhesus macaque TIMM17B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1914-Ab-1/ GM-Tg-felg-IP1914-Ab-2Anti-Feline TIMM17B monoclonal antibodyFeline
GM-Tg-cang-IP1914-Ab-1/ GM-Tg-cang-IP1914-Ab-2Anti-Canine TIMM17B monoclonal antibodyCanine
GM-Tg-bovg-IP1914-Ab-1/ GM-Tg-bovg-IP1914-Ab-2Anti-Bovine TIMM17B monoclonal antibodyBovine
GM-Tg-equg-IP1914-Ab-1/ GM-Tg-equg-IP1914-Ab-2Anti-Equine TIMM17B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1914-Ab-1/ GM-Tg-hg-IP1914-Ab-2; GM-Tg-rg-IP1914-Ab-1/ GM-Tg-rg-IP1914-Ab-2;
GM-Tg-mg-IP1914-Ab-1/ GM-Tg-mg-IP1914-Ab-2; GM-Tg-cynog-IP1914-Ab-1/ GM-Tg-cynog-IP1914-Ab-2;
GM-Tg-felg-IP1914-Ab-1/ GM-Tg-felg-IP1914-Ab-2; GM-Tg-cang-IP1914-Ab-1/ GM-Tg-cang-IP1914-Ab-2;
GM-Tg-bovg-IP1914-Ab-1/ GM-Tg-bovg-IP1914-Ab-2; GM-Tg-equg-IP1914-Ab-1/ GM-Tg-equg-IP1914-Ab-2
Products NameAnti-TIMM17B monoclonal antibody
Formatmab
Target NameTIMM17B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TIMM17B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1914-Ag-1Recombinant multi-species TI17B/ TIMM17B/ DXS9822 protein


    Target information

    Target IDGM-IP1914
    Target NameTIMM17B
    Gene ID10245,21855,317374,714895,480908,101096954,540765,100051797
    Gene Symbol and Synonyms17kDa,DXS9822,JM3,mTim17b,RGD1561744,Sfc3,TIM17B,TIMM17B
    Uniprot AccessionO60830,Q2HJE9
    Uniprot Entry NameTI17B_HUMAN,TI17B_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000126768
    Target ClassificationN/A

    The target: TIMM17B, gene name: TIMM17B, also named as DXS9822, JM3, TIM17B. This gene encodes a multipass transmembrane protein that forms an integral component of the mitochondrial translocase TIM23 complex. This complex facilitates the transport of mitochondrial proteins from the cytosol across the mitochondrial inner membrane and into the mitochondrion. There is a pseudogene for this gene on chromosome 12. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.